C

CLYM

Climb Bio

10.55

-0.36-3.30%
After Hours: 10.25  -0.30  -2.84%19:19 06/05 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE10.78/10.77
TODAY RANGE10.37-11.48
VOL3.68M
MARKET CAP637.60M
52 WEEK RANGE1.160-12.48
AVG VOL (3M)832.64K
% TURNOVER6.42%
TURNOVER--
P/E (TTM)-14.3529
% RANGE10.31%
EPS(TTM)-0.7758
P/E(FORWARD)-12.9477
P/B3.592
BVPS3.100
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP635.13M
SHARES OUTSTANDING57.26M
NEXT EARNINGS--
FREE FLOAT57.04M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

C

Climb Bio

CLYM

-3.30%
10.55

R

Regeneron Pharmaceuticals

REGN

+1.07%
635.45

G

GridAI Tech

GRDX

+4.79%
6.35

B

BIONTECH

BNTX

-1.69%
88.08

聯合治療

UTHR

+0.40%
549.87

福泰製藥

VRTX

+1.15%
446.83

S

SIGA科技

SIGA

-2.93%
4.300

M

Moderna

MRNA

-8.04%
47.44

C

Charles Riv Labs Intl Inc

CRL

-2.40%
181.34

M

Medpace控股

MEDP

-0.97%
454.25

TLPH

--

I

ICON plc

ICLR

-2.19%
149.45

泰邦生物

CBPO

0.00%
119.99

I

Iqvia Hldgs Inc

IQV

-1.84%
183.45

MOLN

--

吉利德科學

GILD

-0.02%
129.16

A

Arcturus醫療

ARCT

-9.20%
7.30

PRAH

--

APVO

--

因塞特醫療

INCY

+1.13%
102.38

BSTC

--

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.